Evidence-Based Guidance on Prescribing Controlled Substances


About the Course: 
The purpose of this course is to educate health care providers about the requirements of the Controlled Substances Act and safe prescribing practices for both opioid and non-opioid controlled substances. In addition, some of the medical conditions for which controlled substances are most commonly prescribed will be reviewed, along with recommendations for responsible management of these conditions with specific controlled substances. 

“This course will [partially] fulfill the DEA-mandated 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for DEA licensees renewing on or after June 27, 2023.”

Learning Objectives: 
Completion of this course will better enable the course participant to:

  • Discuss optimal treatment regimens when using controlled substances for common medical conditions.
  • Identify preventions for misuse/diversion and safeguards for controlled substances.
  • Understand controlled substance regulations and tools for appropriate prescribing.
  • Discuss diagnosis of OUD and treatments or when to refer to appropriate specialists.

Accreditation Statement 
InforMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

Designation Statement 
InforMed designates this enduring material for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Maintenance of Certification (MOC) information can be viewed here: MOC Recognition Page